期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Orotidine Monophosphate Decarboxylase——A Fascinating Workhorse Enzyme with Therapeutic Potential 被引量:2
1
作者 Masahiro Fujihashi Jagjeet S.Mnpotra +2 位作者 Ram Kumar Mishra Emil F.Pai Lakshmi P.Kotra 《Journal of Genetics and Genomics》 SCIE CAS CSCD 2015年第5期221-234,共14页
Orotidine 5'-monophosphate decarboxylase (ODCase) is known as one of the most proficient enzymes. The enzyme catalyzes the last reaction step of the de novo pyrimidine biosynthesis, the conversion from orotidine 5... Orotidine 5'-monophosphate decarboxylase (ODCase) is known as one of the most proficient enzymes. The enzyme catalyzes the last reaction step of the de novo pyrimidine biosynthesis, the conversion from orotidine 5'-monophosphate (OMP) to uridine 5'-mono- phosphate. The enzyme is found in all three domains of life, Bacteria, Eukarya and Archaea. Multiple sequence alignment of 750 putative ODCase sequences resulted in five distinct groups. While the universally conserved DxKxxDx motif is present in all the groups, depending on the groups, several characteristic motifs and residues can be identified. Over 200 crystal structures of ODCases have been determined so far. The structures, together with biochemical assays and computational studies, elucidated that ODCase utilized both transition state stabilization and substrate distortion to accelerate the decarboxylation of its natural substrate. Stabilization of the vinyl anion intermediate by a conserved lysine residue at the catalytic site is considered the largest contributing factor to catalysis, while bending of the carboxyl group from the plane of the aromatic pyrimidine ring of OMP accounts for substrate distortion. A number of crystal structures of ODCases complexed with potential drug candidate molecules have also been determined, including with 6-iodo- uridine, a potential antimalarial agent. 展开更多
关键词 Pyrimidine biosynthesis Orotidine monophosphate decarboxylase ligand-enzyme interactions Antimalarial agents
原文传递
测定GITR和GITRLELISA的建立及其临床初步应用
2
作者 孙立山 范列英 +3 位作者 张慧 郑慧雅 宗明 朱海波 《检验医学》 CAS 北大核心 2009年第12期891-894,共4页
目的建立测定糖皮质激素诱导的肿瘤坏死因子受体(GITR)及其配体(GITRL)的定量酶联免疫吸附试验(ELISA),并探讨GITR及GITRL定量测定在类风湿性关节炎(RA)及肿瘤疾病的诊断或病情监测中的临床应用。方法以鼠抗人GITR、GITRL单克隆抗体为... 目的建立测定糖皮质激素诱导的肿瘤坏死因子受体(GITR)及其配体(GITRL)的定量酶联免疫吸附试验(ELISA),并探讨GITR及GITRL定量测定在类风湿性关节炎(RA)及肿瘤疾病的诊断或病情监测中的临床应用。方法以鼠抗人GITR、GITRL单克隆抗体为包被抗体,以生物素-辣根过氧化物酶标记链霉亲和素(SA-HRP)检测系统,建立GITR和GITRL定量检测的双抗体夹心ELISA。测定105例RA患者、54例肿瘤患者及100名健康体检者的血清GITR、GITRL含量,并探讨其与疾病的关系。结果建立的测定GITR、GITRL定量ELISA线性相关系数的平方(r2)分别为0.94和0.90。RA组血清中GITR、GITRL含量均明显高于正常对照组(P均<0.001);肿瘤组GITR高于正常对照组(P<0.001),GITRL与正常对照组差异无统计学意义(P>0.05)。结论本研究成功建立了GITR、GITRL定量ELISA,血清GITR、GITRL含量测定可能会成为RA新的辅助性诊断指标和病情监测指标。 展开更多
关键词 糖皮质激素诱导的肿瘤坏死因子受体 糖皮质激素诱导的肿瘤坏死因子受体配体 酶联免疫吸附试验 类风湿性关节炎
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部